https://doi.org/10.1016/j.jacbts.2018.09.004
B
Bidda Rolin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
3.0K
Citations
27
h-index
38
i10-index
Bidda Rolin is an academic researcher from Novo Nordisk (Denmark). The author has contributed to research in topics: Pancreatic function and diabetes & Diabetes Treatment and Management & Diabetes Management and Research. The author has an h-index of 27, co-authored 60 publications.
ORCID: 0000-0001-8430-3540Papers by this author
worksThe GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways
2018 · JACC Basic to Translational Science · 437 citations
Effect of captopril on post-infarction remodelling visualized by light sheet microscopy and echocardiography
2021 · Scientific Reports · 16 citations
https://doi.org/10.1038/s41598-021-84812-7
Semaglutide treatment attenuates vessel remodelling in ApoE−/− mice following vascular injury and blood flow perturbation
2022 · Atherosclerosis Plus · 15 citations
https://doi.org/10.1016/j.athplu.2022.05.004
Deep learning reveals 3D atherosclerotic plaque distribution and composition
2020 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-020-78632-4
Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis
2025 · Journal of Lipid Research · 2 citations
https://doi.org/10.1016/j.jlr.2025.100753
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat